Nature's Miracle Holding Inc. (NMHI) Cash Flow Statement
Where NMHI’s cash came from and went, FY2025
September 30, 2025 · U.S. dollars- Cash from operations
- −$4.0M
- Capital expenditures
- $0 0.0% of revenue
- Free cash flow
- −$4.0M −228.7% margin
- Returned to shareholders
- —
- Change in cash
- −$322,437 cash at year-end $97,694
Cash from operations
−$4.0M
Net borrowing (repayment)
+$2.1M
Shares issued
+$1.5M
Other financing
+$878,295
Currency & other
−$863,083
Change in cash
−$322,437
Drawn to scale: where the cash came from and how it was used. Hover for values.
NMHI operating cash flow, capex and free cash flow
Operating cash flowCapital expendituresFree cash flowFCF margin (right axis)
NMHI cash flow trends, FY2020–FY2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Operating cash flow | $466,213FY2020 | −$4.0MFY2025 | — | |
| Capital expenditures | $70,928FY2020 | $0FY2025 | −100.0% | |
| Free cash flow | $395,285FY2020 | −$4.0MFY2025 | — | |
| Free cash flow margin | 3.7%FY2020 | −228.7%FY2025 | −232.4 pts | |
| Operating cash flow / net income | 1.00FY2020 | 1.82FY2021 | +0.82 | |
| Stock-based compensation | $0FY2023 | $341,462FY2025 | — | |
| Capex / revenue | 0.7%FY2020 | 0.0%FY2025 | −0.7 pts |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
NMHI cash flow by activity
OperatingInvestingFinancingChange in cash
NMHI net income vs operating cash flow
Net incomeOperating cash flow
Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).
NMHI cash flow statement
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Operating activities | ||||||
| Net income | −$12.0M | −$7.3M | −$7.3M | −$2.5M | $1.1M | $464,976 |
| Depreciation & amortization | $749,549 | $536,681 | $536,681 | $424,786 | $126,849 | $29,689 |
| Stock-based compensation | $341,462 | $1.4M | $0 | — | — | — |
| Change in working capital | $2.7M | $1.4M | $1.4M | −$688,000 | $766,247 | −$114,681 |
| Other non-cash items | $4.3M | $2.4M | $3.8M | $271,500 | $42,017 | $86,229 |
| Cash from operating activities | −$4.0M | −$1.7M | −$1.7M | −$2.5M | $2.1M | $466,213 |
| Investing activities | ||||||
| Capital expenditures | $0 | −$4 | −$4 | −$52,894 | −$18,416 | −$70,928 |
| Investments (net) | — | −$40,000 | −$437,087 | −$269,775 | −$1.2M | −$216,928 |
| Financing activities | ||||||
| Net borrowing (repayment) | $2.1M | $2.6M | $2.0M | $2.0M | −$21,959 | — |
| Shares issued | $1.5M | $3.3M | $0 | $394,000 | $40,000 | $100,000 |
| Other financing | $878,295 | −$4.4M | −$465,875 | −$197,056 | $23,813 | $0 |
| Cash from financing activities | $4.5M | $1.5M | $1.5M | $2.2M | $41,854 | $100,000 |
| Summary | ||||||
| Net change in cash | −$322,437 | −$588,611 | −$588,611 | −$502,226 | $920,155 | $349,285 |
| Cash at end of period | $97,694 | $221,760 | $221,760 | $810,371 | $1.3M | $489,851 |
| Free cash flow | −$4.0M | −$1.7M | −$1.7M | −$2.5M | $2.1M | $395,285 |
| Free cash flow margin | −228.7% | −18.8% | −18.8% | −13.5% | 14.3% | 3.7% |
| Capex / revenue | 0.0% | 0.0% | 0.0% | 0.3% | 0.1% | 0.7% |
| Operating cash flow / net income | — | — | — | — | 1.82 | 1.00 |
| Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | Jun '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||||||
| Net income | $2.8M | −$6.0M | −$2.2M | −$1.8M | −$2.0M | −$6.8M | −$2.8M | −$1.8M | −$2.3M | −$6.0M | −$403,966 | −$406,570 |
| Depreciation & amortization | $170,218 | $406,769 | $63,849 | $124,870 | $154,086 | $152,033 | $148,752 | $135,076 | $99,939 | $124,065 | $124,496 | $134,654 |
| Stock-based compensation | $104,795 | $111,423 | $84,146 | $60,957 | $84,936 | $197,578 | $848,075 | $195,908 | $171,897 | — | $0 | $0 |
| Change in working capital | $232,106 | −$67,897 | $513,257 | $1.1M | $1.2M | $1.1M | $133,409 | $433,636 | $271,763 | $1.5M | −$248,525 | $63,078 |
| Other non-cash items | −$5.0M | $3.4M | $649,120 | $204,839 | $36,586 | $2.6M | $191,898 | $34,606 | $989,785 | $3.5M | $207,723 | $145,382 |
| Cash from operating activities | −$1.6M | −$2.2M | −$896,458 | −$314,853 | −$594,171 | −$2.8M | −$1.4M | −$969,093 | −$773,422 | −$862,585 | −$320,272 | −$63,456 |
| Investing activities | ||||||||||||
| Capital expenditures | −$1.0M | $0 | $0 | $0 | $0 | $0 | $0 | −$3 | $0 | $0 | $0 | $0 |
| Investments (net) | — | — | −$142,359 | −$421,000 | −$300,000 | −$197 | $197 | $197 | −$39,803 | −$180,000 | −$240,000 | −$70,036 |
| Financing activities | ||||||||||||
| Share repurchases & issuance (net) | — | — | — | — | — | — | — | — | — | — | — | −$6.8M |
| Net borrowing (repayment) | $2.4M | $1.5M | $446,039 | $450,022 | −$336,073 | $342,520 | $395,635 | — | — | — | — | — |
| Shares issued | $128,752 | $660,410 | $0 | $0 | $0 | $2.3M | $0 | $0 | $0 | $0 | $0 | $0 |
| Other financing | $6,946 | $12,247 | $644,662 | $277,825 | $827,370 | $496,630 | $1.0M | $699,589 | $891,537 | $541,367 | −$78,421 | $8.0M |
| Cash from financing activities | $2.6M | $2.2M | $1.1M | $727,847 | $491,297 | $3.1M | $1.4M | $699,589 | $891,537 | $541,367 | −$78,421 | $1.2M |
| Summary | ||||||||||||
| Net change in cash | −$51,999 | $36,244 | $51,939 | −$8,141 | −$402,479 | $380,017 | $9,582 | −$269,590 | $78,362 | −$501,307 | −$638,609 | $1.0M |
| Cash at end of period | $45,695 | $97,694 | $61,450 | $9,511 | $17,652 | $420,131 | $40,114 | $30,532 | $300,122 | $221,760 | $723,067 | $1.4M |
| Free cash flow | −$2.6M | −$2.0M | −$1.1M | −$314,853 | −$594,171 | −$2.8M | −$1.4M | −$969,090 | −$773,422 | −$862,585 | −$320,272 | −$63,456 |
| Free cash flow margin | −6,262.7% | −2,500.8% | −1,514.9% | −65.1% | −53.7% | −461.3% | −46.8% | −28.5% | −35.1% | −64.8% | −11.9% | −3.3% |
| Capex / revenue | 2,403.6% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating cash flow / net income | −0.56 | — | — | — | — | — | — | — | — | — | — | — |
Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.
NMHI cash generation
In fiscal 2025 (ended September 30, 2025), Nature's Miracle generated -$4.0 million of cash from operations and spent $0 on capital expenditures, leaving free cash flow of -$4.0 million, −228.7% of revenue. Cash and equivalents fell by $0.3 million over the year.
Related: NMHI income statement, NMHI balance sheet. See the NMHI stock overview for the latest quote and news.
NMHI cash flow FAQ
What is Nature's Miracle's free cash flow?
Nature's Miracle's free cash flow was -$4.0 million in fiscal 2025: -$4.0 million of operating cash flow minus $0 of capital expenditures It was -$1.7 million a year earlier..
How much cash does Nature's Miracle generate from operations?
Nature's Miracle generated -$4.0 million of cash from operating activities in fiscal 2025.